MYBBP1A Antikörper (N-Term)

Produktnummer ABIN2838613

Produktdetails anti-MYBBP1A Antikörper

Target: MYBBP1A (Myb-Binding Protein 1A (MYBBP1A))

Bindungsspezifität: AA 258-287, N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MYBBP1A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This MYBBP1A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 258-287 amino acids from the N-terminal region of human MYBBP1A.

Klon: RB23244

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-MYBBP1A Antikörper (ABIN2838613)

Perrera, Colombo, Valsasina, Carpinelli, Troiani, Modugno, Gianellini, Cappella, Isacchi, Moll, Rusconi: "Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase." in: The Journal of biological chemistry, Vol. 285, Issue 16, pp. 11775-85, (2010) (PubMed).

Fuller, Man, Lam, Thanh, Keough, Asperger, Gonda, Morris: "The SMN interactome includes Myb-binding protein 1a." in: Journal of proteome research, Vol. 9, Issue 1, pp. 556-63, (2010) (PubMed).

Redmond, Bane, Stafford, McIlroy, Dillon, Crotty, Hill, Young: "Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 15, Issue 6, pp. 2098-106, (2009) (PubMed).

Al-azawi, Ilroy, Kelly, Redmond, Bane, Cocchiglia, Hill, Young: "Ets-2 and p160 proteins collaborate to regulate c-Myc in endocrine resistant breast cancer." in: Oncogene, Vol. 27, Issue 21, pp. 3021-31, (2008) (PubMed).

Lu, Dollé, Imholz, van t Slot, Verschuren, Wijmenga, Feskens, Boer: "Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations." in: Journal of lipid research, Vol. 49, Issue 12, pp. 2582-9, (2008) (PubMed).

Details zu MYBBP1A

Target: MYBBP1A (Myb-Binding Protein 1A (MYBBP1A))

Andere Bezeichnung: MYBBP1A (MYBBP1A Produkte)

Synonyme: MYBBP1A antikoerper, MGC98482 antikoerper, p160 antikoerper, pap2 antikoerper, AL024407 antikoerper, AU019902 antikoerper, P160 antikoerper, p160MBP antikoerper, p67MBP antikoerper, DBP antikoerper, PAP2 antikoerper, cb486 antikoerper, sb:cb486 antikoerper, MYB binding protein 1a antikoerper, MYB binding protein (P160) 1a S homeolog antikoerper, myb-binding protein 1A antikoerper, MYB binding protein (P160) 1a antikoerper, MYBBP1A antikoerper, mybbp1a.S antikoerper, mybbp1a antikoerper, LOC100413205 antikoerper, Mybbp1a antikoerper

Hintergrund: MYBBP1A may activate or repress transcription via interactions with sequence specific DNA-binding proteins. Repression may be mediated at least in part by histone deacetylase activity (HDAC activity) (By similarity).

Molekulargewicht: 148855

NCBI Accession: NP_001099008, NP_055335

UniProt: Q9BQG0